Invention Grant
- Patent Title: Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters
-
Application No.: US15017853Application Date: 2016-02-08
-
Publication No.: US09636409B2Publication Date: 2017-05-02
- Inventor: Alan Hastings Drummond , Alan Hornsby Davidson , David Festus Charles Moffat , Alastair David Graham Donald , Stephen John Davies
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Duke M. Fitch; Kathryn A. Lutomski; Edward R. Gimmi
- Priority: GB0803747.5 20080229
- Main IPC: C07D211/70
- IPC: C07D211/70 ; C07D211/82 ; C07D213/55 ; C07D213/56 ; A61K31/44 ; A61K47/48 ; C07D213/73 ; C12Q1/48 ; A61K31/4418

Abstract:
Covalent conjugates of an α,α-disubstituted glycine ester and a modulator of the activity of a target intracellular enzyme or receptor, wherein the ester group of the conjugate is hydrolysable by one or more intracellular carboxylesterase enzymes to the corresponding acid and the α,α-disubstituted glycine ester is conjugated to the modulator at a position remote from the binding interface between the inhibitor and the target enzyme or receptor pass into cells and the active acid hydrolysis product accumulates within the cells, as in the following compound:
Public/Granted literature
- US20160151509A1 ENZYME AND RECEPTOR MODULATION Public/Granted day:2016-06-02
Information query